HCC patients with elevated SSTR2 expression may be ideal candidates for 68Ga-DOTATATE PET/CT imaging, a molecular imaging modality that can provide superior tumor detection, evaluate treatment response, and guide patient stratification for targeted therapies [49]. Here, SSTR2 is linked to hepatocellular carcinoma.